A randomized comparison of paclitaxel-eluting stents versus bare-metal stents for treatment of unpro- tected left main coronary artery stenosis. J Am Coll Cardiol. 2007;50: 491 7. 475. Price MJ, Cristea E, Sawhney N, et al. Serial angiographic follow-up of sirolimus-eluting stents for unprotected left main coronary artery revas- cularization. J Am Coll Cardiol. 2006;47:871 7. 476. Cutlip DE, Baim DS, Ho KK, et al. Stent thrombosis in the modern era: a pooled analysis of multicenter coronary stent clinical trials. Circu- lation. 2001;103:1967 71. 477. Singh M, Gersh BJ, McClelland RL, et al. Predictive factors for ische- mic target vessel revascularization in the Prevention of Restenosis with Tranilast and its Outcomes (PRESTO) trial. J Am Coll Cardiol. 2005; 45:198 203. 478. Schulz S, Schuster T, Mehilli J, et al. Stent thrombosis after drug-eluting stent implantation: incidence, timing, and relation to discontinuation of clopidogrel therapy over a 4-year period. Eur Heart J. 2009;30:2714 21. 479. Nordmann AJ, Hengstler P, Harr T, et al. Clinical outcomes of primary stenting versus balloon angioplasty in patients with myocar-dial infarc- tion: a meta-analysis of randomized controlled trials. Am J Med. 2004; 116:253 62. 480. Gao F, Zhou YJ, Wang ZJ, et al. Meta-analysis of the combination of warfarin and dual antiplatelet therapy after coronary stenting in patients with indications for chronic oral anticoagulation. Int J Cardiol. 2011; 148:96 101. 481. Levine GN, Gomes AS, Arai AE, et al. Safety of magnetic resonance imaging in patients with cardiovascular devices: an American Heart Association scientific statement from the Committee on Diagnostic and Interventional Cardiac Catheterization, Council on Clinical Cardiology, and the Council on Cardiovascular Radiology and Intervention. Circu- lation. 2007;116:2878 91. 482. Hundley WG, Bluemke DA, Finn JP, et al. ACCF/ACR/AHA/ NASCI/SCMR 2010 expert consensus document on cardiovascular magnetic resonance. Circulation. 2010;121:2462 508. 483. 